285 related articles for article (PubMed ID: 22449146)
1. From neurodevelopment to neurodegeneration: the interaction of neurofibromin and valosin-containing protein/p97 in regulation of dendritic spine formation.
Hsueh YP
J Biomed Sci; 2012 Mar; 19(1):33. PubMed ID: 22449146
[TBL] [Abstract][Full Text] [Related]
2. Valosin-containing protein and neurofibromin interact to regulate dendritic spine density.
Wang HF; Shih YT; Chen CY; Chao HW; Lee MJ; Hsueh YP
J Clin Invest; 2011 Dec; 121(12):4820-37. PubMed ID: 22105171
[TBL] [Abstract][Full Text] [Related]
3. Another VCP interactor: NF is enough.
Weihl CC
J Clin Invest; 2011 Dec; 121(12):4627-30. PubMed ID: 22105166
[TBL] [Abstract][Full Text] [Related]
4. Vcp Overexpression and Leucine Supplementation Increase Protein Synthesis and Improve Fear Memory and Social Interaction of Nf1 Mutant Mice.
Shih YT; Huang TN; Hu HT; Yen TL; Hsueh YP
Cell Rep; 2020 Jun; 31(13):107835. PubMed ID: 32610136
[TBL] [Abstract][Full Text] [Related]
5. Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region.
Song C; Wang Q; Song C; Lockett SJ; Colburn NH; Li CC; Wang JM; Rogers TJ
Biochim Biophys Acta; 2015 Jan; 1853(1):222-32. PubMed ID: 25447673
[TBL] [Abstract][Full Text] [Related]
6. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.
Ju JS; Weihl CC
Hum Mol Genet; 2010 Apr; 19(R1):R38-45. PubMed ID: 20410287
[TBL] [Abstract][Full Text] [Related]
7. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
Weihl CC; Miller SE; Hanson PI; Pestronk A
Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
[TBL] [Abstract][Full Text] [Related]
8. Valosin-containing protein (VCP) is a novel IQ motif-containing GTPase activating protein 1 (IQGAP1)-interacting protein.
Itoh N; Nagai T; Watanabe T; Taki K; Nabeshima T; Kaibuchi K; Yamada K
Biochem Biophys Res Commun; 2017 Dec; 493(4):1384-1389. PubMed ID: 28970065
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
[TBL] [Abstract][Full Text] [Related]
10. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
Weihl CC; Dalal S; Pestronk A; Hanson PI
Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
Chang YC; Hung WT; Chang YC; Chang HC; Wu CL; Chiang AS; Jackson GR; Sang TK
PLoS Genet; 2011 Feb; 7(2):e1001288. PubMed ID: 21304887
[TBL] [Abstract][Full Text] [Related]
12. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy.
Ching JK; Elizabeth SV; Ju JS; Lusk C; Pittman SK; Weihl CC
Hum Mol Genet; 2013 Mar; 22(6):1167-79. PubMed ID: 23250913
[TBL] [Abstract][Full Text] [Related]
13. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.
Rodriguez-Ortiz CJ; Hoshino H; Cheng D; Liu-Yescevitz L; Blurton-Jones M; Wolozin B; LaFerla FM; Kitazawa M
Am J Pathol; 2013 Aug; 183(2):504-15. PubMed ID: 23747512
[TBL] [Abstract][Full Text] [Related]
14. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation.
Halawani D; LeBlanc AC; Rouiller I; Michnick SW; Servant MJ; Latterich M
Mol Cell Biol; 2009 Aug; 29(16):4484-94. PubMed ID: 19506019
[TBL] [Abstract][Full Text] [Related]
15. IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation.
Bayraktar O; Oral O; Kocaturk NM; Akkoc Y; Eberhart K; Kosar A; Gozuacik D
PLoS One; 2016; 11(10):e0164864. PubMed ID: 27768726
[TBL] [Abstract][Full Text] [Related]
16. Valosin containing protein associated fronto-temporal lobar degeneration: clinical presentation, pathologic features and pathogenesis.
Weihl CC
Curr Alzheimer Res; 2011 May; 8(3):252-60. PubMed ID: 21222596
[TBL] [Abstract][Full Text] [Related]
17. The Cure VCP Scientific Conference 2021: Molecular and clinical insights into neurodegeneration and myopathy linked to multisystem proteinopathy-1 (MSP-1).
Johnson MA; Klickstein JA; Khanna R; Gou Y; ; Raman M
Neurobiol Dis; 2022 Jul; 169():105722. PubMed ID: 35405261
[TBL] [Abstract][Full Text] [Related]
18. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD.
Tresse E; Salomons FA; Vesa J; Bott LC; Kimonis V; Yao TP; Dantuma NP; Taylor JP
Autophagy; 2010 Feb; 6(2):217-27. PubMed ID: 20104022
[TBL] [Abstract][Full Text] [Related]
19. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.
Vesa J; Su H; Watts GD; Krause S; Walter MC; Martin B; Smith C; Wallace DC; Kimonis VE
Neuromuscul Disord; 2009 Nov; 19(11):766-72. PubMed ID: 19828315
[TBL] [Abstract][Full Text] [Related]
20. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.
Ju JS; Fuentealba RA; Miller SE; Jackson E; Piwnica-Worms D; Baloh RH; Weihl CC
J Cell Biol; 2009 Dec; 187(6):875-88. PubMed ID: 20008565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
